I am a healthcare professional in the UK
I am a patient or member of the public
1 minute
ESCMID 2025 Congress Review
This post-congress highlights podcast from ESCMID 2025 features Dr Sowsan Atabani, Consultant Virologist and Clinical Lead for Virology at the UK Health Security Agency South West Regional Laboratory, Bristol sharing her key congress highlights in transplant and infectious diseases. She discusses top papers in transplant ID (including expanding donor pools with HIV positive kidneys and infection risks following CAR T therapy), evolving strategies for donor and recipient screening (with a focus on HHV8/Kaposi sarcoma virus), and a keynote on the past, present and future of infections in transplant recipients. Dr Atabani also reviews new European recommendations on congenital CMV screening and antiviral use in early pregnancy, the growing role of AI in diagnostics, surveillance and guideline development.
Brightcove Video
You might be interested in
1 minute
download
This concise guide to LIVTENCITY® (maribavir) is designed for clarity and ease of use. It summarises key insights from the Phase 3 SOLSTICE trial, including efficacy outcomes, safety data, and practical dosing guidance.
article
6 minutes
A summary of the safety profile of LIVTENCITY, including adverse event data and tolerability findings from clinical studies.
article
5 minutes
Key efficacy outcomes from clinical trials evaluating LIVTENCITY in patients with post-transplant CMV, including virologic response and treatment comparisons.
article
3 minutes
CMV is one of the most common infections experienced by transplant recipients
article
4 minutes
An overview of the pivotal Phase 3 SOLSTICE trial, outlining the study design, patient population, and methodology that underpin the clinical evidence for LIVTENCITY.
